Literature DB >> 3978826

Multiple intracranial metastases from a prolactin secreting pituitary tumour.

R W Gasser, G Finkenstedt, F Skrabal, K Twerdy, V Grunert, U Mayr, H Frommhold, D Zur Nedden, J Feichtinger, F Hofstaedter.   

Abstract

A 28 year old man presented with partial hypopituitarism and signs of a pituitary tumour. A chromophobe adenoma was partially removed by right frontal craniotomy. Seven years later complete hypopituitarism and hyperprolactinaemia were documented, at which time there was no evidence of tumour recurrence of CT scan. The patient was treated with bromocriptine but the pituitary tumour redeveloped a year later. Nine years after the original operation the first metastasis was demonstrated together with very high prolactin levels. The intracranial metastasis, and the pituitary tumour were removed at a second craniotomy following which the prolactin concentration fell. Further metastases developed subsequently and the patient died 12 years after the initial diagnosis. At autopsy multiple metastases were found in the brain, tumour cells were present in the subarachnoid space and in cerebral veins. The pituitary tumour and secondaries were shown by immunocytochemistry to contain prolactin but not ACTH or growth hormone. This appears to be the third well documented case of a metastasizing, prolactin secreting pituitary tumour.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978826     DOI: 10.1111/j.1365-2265.1985.tb01060.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Malignant pituitary tumours.

Authors:  G A Kaltsas; A B Grossman
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

2.  Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma.

Authors:  M Fujikawa; K Okamura; K Sato; M Shiratsuchi; T Yao; T Mizokami; M Fujishima
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 3.  Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.

Authors:  M Sironi; G Cenacchi; L Cozzi; G Tonnarelli; M Iacobellis; D Treré; A Assi
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 4.  Intracranial dissemination of pituitary adenoma. Case report and review of the literature.

Authors:  M T Giordana; P Cavalla; A Allegranza; B Pollo
Journal:  Ital J Neurol Sci       Date:  1994-05

5.  Late development of frontal prolactinoma after resection of pituitary tumor.

Authors:  Jesús Vaquero; José Herrero; Rafael Cincu
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

6.  Dopaminergic resistance in a case of invasive macroprolactinoma.

Authors:  D Schwarzstein; A García-Patterson; G Giménez; J Calaf; M Puig-Domingo; A Caixàs; X Matías-Guiu; S M Webb
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

7.  Prolactin secreting pituitary carcinoma.

Authors:  T Petterson; I A MacFarlane; J M MacKenzie; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

8.  Pituitary Carcinomas.

Authors:  Wolfgang Saeger; Dorothee Lubke
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 9.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

10.  Long-term follow-up of growth hormone-producing pituitary carcinoma with multiple spinal metastases following multiple surgeries: case report.

Authors:  Toshihide Tanaka; Naoki Kato; Ken Aoki; Mitsuyoshi Watanabe; Takao Arai; Yuzuru Hasegawa; Toshiaki Abe
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.